Medicenna Therapeutics (MDNAF) Earnings Date & Reports
A.I. Advisor
published Earnings
MDNAF is expected to report earnings to rise 10.25% to -3 cents per share on November 15
Q3'24
Est.
$-0.04
Q2'24
Est.
$-0.03
Q1'24
Missed
by $0.01
Q4'23
Est.
$-0.05
Q3'23
Est.
$-0.03
The last earnings report on August 02 showed earnings per share of -3 cents, missing the estimate of -3 cents. With 154.26K shares outstanding, the current market capitalization sits at 125.60M.